GILEAD SCIENCES, INC. has filed 25 insider transactions across 4 companies since June 2023.
Most recent transaction: a purchase of 3739000 shares of GILEAD SCIENCES, INC. ($GILD) on February 13, 2026.
Activity breakdown: 20 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 3739000 | $0.53 | 40,384,266.0000 | 1,256,000,000 | 10.20% | 0.30% |
| Nov. 26, 2025 | Xilio Therapeutics, Inc. | $XLO | GILEAD SCIENCES, INC. | TenPercentOwner | X | Prefunded Warrants (right to buy) | 13335000 | $0.75 | 36,645,266.0000 | 144,106,869 | 57.21% | 9.25% |
| Nov. 26, 2025 | Xilio Therapeutics, Inc. | $XLO | GILEAD SCIENCES, INC. | TenPercentOwner | X | Series B Warrants (right to buy) | 13335000 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 9.25% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 2295920 | $0.00 | 4,505,391.0000 | 1,255,000,000 | 103.91% | 0.18% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Class B warrants to purchase Common Stock | 1147960 | $0.00 | 1,147,960.0000 | 1,255,000,000 | 9999.99% | 0.09% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Class A warrants to purchase Common Stock | 1147960 | $0.00 | 1,147,960.0000 | 1,255,000,000 | 9999.99% | 0.09% |
| June 5, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 13335000 | $0.00 | 23,310,266.0000 | 1,255,000,000 | 133.68% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series A Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series B Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series C Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| Feb. 18, 2025 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1363636 | $11.00 | 31,424,760.0000 | 1,255,000,000 | 4.54% | 0.11% |
| Dec. 19, 2024 | ASSEMBLY BIOSCIENCES, INC. | $ASMB | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 940499 | $21.37 | 2,209,471.0000 | 0 | 74.12% | 0.00% |
| Dec. 18, 2024 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1759978 | $1.04 | 9,105,451.0000 | 1,254,000,000 | 23.96% | 0.14% |
| Dec. 18, 2024 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 6092816 | $1.04 | 9,975,266.0000 | 1,254,000,000 | 156.93% | 0.49% |
| June 17, 2024 | ASSEMBLY BIOSCIENCES, INC. | $ASMB | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 179500 | $0.00 | 1,268,972.0000 | 0 | 16.48% | 0.00% |
| June 17, 2024 | ASSEMBLY BIOSCIENCES, INC. | $ASMB | GILEAD SCIENCES, INC. | TenPercentOwner | P | Warrant to purchase Common Stock | 179500 | $0.00 | 179,500.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 485250 | $0.76 | 7,345,473.0000 | 1,258,000,000 | 7.07% | 0.04% |
| April 2, 2024 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 3882450 | $0.76 | 3,882,450.0000 | 1,258,000,000 | 9999.99% | 0.31% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 910000 | $22.00 | 4,126,119.0000 | 0 | 28.29% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | GILEAD SCIENCES, INC. | TenPercentOwner | C | Common Stock | 3216119 | $0.00 | 3,216,119.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | GILEAD SCIENCES, INC. | TenPercentOwner | C | Series B Convertible Preferred Stock | 7746139 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | GILEAD SCIENCES, INC. | TenPercentOwner | C | Series A-2 Convertible Preferred Stock | 6890744 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 15238095 | $21.00 | 30,061,124.0000 | 1,258,000,000 | 102.80% | 1.21% |
| June 28, 2023 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1010000 | $19.26 | 14,823,029.0000 | 1,262,000,000 | 7.31% | 0.08% |
| June 27, 2023 | GILEAD SCIENCES, INC. | $GILD | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 2930870 | $3.75 | 16,635,286.0000 | 1,262,000,000 | 21.39% | 0.23% |